Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on July 6, 2026

Jul. 6, 2026

Mercer International Inc. Announces Conference Call for Second Quarter 2026 Results

Indeterminate GlobeNewswire

Jul. 6, 2026

Wintrust to purchase Northern Trust guardianship services business

Indeterminate GlobeNewswire

Jul. 6, 2026

CubeSmart Announces the Date of Its Second Quarter 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire

Jul. 6, 2026

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Indeterminate GlobeNewswire

Jul. 6, 2026

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

Indeterminate GlobeNewswire

Jul. 6, 2026

Celestica Q2 2026 Financial Results and Conference Call Tuesday, July 28, 2026

Indeterminate GlobeNewswire

Jul. 6, 2026

SEALSQ Corp Reports Preliminary H1 2026 Results; Revenue up 120%, FY 2026 Guidance Reaffirmed

Indeterminate GlobeNewswire

Jul. 6, 2026

Vireo Growth Inc. Engages Independent Trading Group (ITG), Inc. as Market Maker

Indeterminate GlobeNewswire

Jul. 6, 2026

Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

Jul. 6, 2026

Abivax Announces Closing of $920 Million Public Offering

Indeterminate GlobeNewswire

Jul. 6, 2026

Abivax annonce la réalisation de son offre au public de 920 millions de dollars

Indeterminate GlobeNewswire

Jul. 6, 2026

Sprout Social to Announce Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

Jul. 6, 2026

Longeveron® Appoints Marie Washburn as Chief Financial Officer

Indeterminate GlobeNewswire

Jul. 6, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Navitas Semiconductor to Report Q2 2026 Financial Results on Monday, July 27, 2026

Indeterminate GlobeNewswire

Jul. 6, 2026

Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis

Indeterminate GlobeNewswire

Jul. 6, 2026

Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection

Indeterminate GlobeNewswire

Jul. 6, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering

Indeterminate GlobeNewswire

Jul. 6, 2026

MemeToro Launches BNB AI Agent for Fair-Launch Memecoin Creation and On-Chain Prediction Markets

Indeterminate GlobeNewswire